Association between the Pro12Ala polymorphism of PPAR-γ gene and the polycystic ovary syndrome: A meta-analysis of case-control studies

Gene

Volumn 503, Issue 1, 2012, Pages 12-17

  Zhang, Hong ^a,b   Bi, Yan ^a   Hu, Changjun ^b   Lu, Weiping ^b   Zhu, Dalong ^a  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Peroxisome proliferator activated receptor ; Polycystic ovary syndrome; Polymorphism

Indexed keywords

ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE;

ARTICLE; ASIA; CASE CONTROL STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ETHNICITY; EUROPE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HUMAN; INSULIN RESISTANCE; META ANALYSIS; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PUBLISHING; RISK REDUCTION;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; PPAR GAMMA; PUBLICATION BIAS;

EID: 84861791632     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.04.083     Document Type: Article

References (50)

1. Antoine H.J., Pall M., Trader B.C., Chen Y.D., Azziz R., Goodarzi M.O. Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. Fertil. Steril. 2007, 87:862-869.
2. Azziz R. Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil. Steril. 2005, 83:1343-1346.
3. Azziz R., et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J. Clin. Endocrinol. Metab. 2001, 86:1626-1632.
4. Bidzińska-Speichert, Lenarcik A., Tworowska-Bardzińska U., Slezak R., Bednarek-Tupikowska G., Milewicz A. Pro12Ala PPAR gamma2 gene polymorphism in women with polycystic ovary syndrome. Ginekol. Pol. 2011, 82:426-429.
5. Buzzetti R., et al. PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity. Pediatr. Res. 2005, 57:138-140.
6. Chae S.J., Kim J.J., Choi Y.M., Kim J.M., Cho Y.M., Moon S.Y. Peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha gene polymorphisms in Korean women with polycystic ovary syndrome. Gynecol. Obstet. Invest. 2010, 70:1-7.
7. Chen Z.J., Zhao H., He L., Shi Y.H., Qin Y.Y., Shi Y.Y. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat. Genet. 2011, 43:55-59.
8. Christopoulos P., et al. Peroxisome proliferator-activated receptor-γ and -δ polymorphisms in women with polycystic ovary syndrome. Ann. N. Y. Acad. Sci. 2010, 1205:185-191.
9. Colhoun H.M., McKeigue P.M., Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003, 361:865-872.
10. Deligeoroglou E., Kouskouti C., Christopoulos P. The role of genes in the polycystic ovary syndrome: predisposition and mechanisms. Gynecol. Endocrinol. 2009, 25:603-609.
11. Deseminian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:133-188.
12. Gouda H.N., Sagoo G.S., Harding A.H., Yates J., Sandhu M.S., Higgins J.P. The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) variant and type 2 diabetes mellitus: a huge review and meta-analysis. Am. J. Epidemiol. 2010, 171:645-655.
13. Gu B.H., Baek K.H. Pro12Ala and His447His polymorphisms of PPAR-gamma are associated with polycystic ovary syndrome. Reprod. Biomed. Online 2009, 18:644-650.
14. Guzman N., Erices L., Valdes P., Salazar L. A common 34C>G variant at the peroxisome proliferator-activated receptor-2 gene in Chilean women with polycystic ovary syndrome and controls. Int. J. Morphol. 2007, 25:867-873.
15. Haap M., et al. Genetic determinants of insulin action in polycystic ovary syndrome. Exp. Clin. Endocrinol. Diabetes 2005, 113:275-281.
16. Hahn S., et al. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf) 2005, 62:573-579.
17. Hara M., Alcoser S.Y., Qaadir A., Beiswenger K.K., Cox N.J., Ehrmann D.A. Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPAR-gamma gene. J. Clin. Endocrinol. Metab. 2002, 87:772-775.
18. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21:1539-1558.
19. Huguenin G.V., Rosa G. The Ala allele in the PPAR-gamma2 gene is associated with reduced risk of type 2 diabetes mellitus in Caucasians and improved insulin sensitivity in overweight subjects. Br. J. Nutr. 2010, 104:488-497.
20. Jakubowski L. Genetic aspects of polycystic ovary syndrome. Endokrynol. Pol. 2005, 56:285-293.
21. Jing Y.L., Sun Q.M., Bi Y., Shen S.M., Zhu D.L. SLC30A8 polymorphism and type 2 diabetes risk: evidence from 27 study groups. Nutr. Metab. Cardiovasc. Dis. 2011, 21:398-405.
22. Kahara T., et al. PPARgamma gene polymorphism is associated with exercise-mediated changes of insulin resistance in healthy men. Metabolism 2003, 52:209-212.
23. Katsiki N., Hatzitolios A.I. Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update. Curr. Opin. Obstet. Gynecol. 2010, 22:466-476.
24. Knebel B., et al. Increased low grade inflammatory serum markers in patients with polycystic ovary syndrome (PCOS) and their relationship to PPARgamma gene variants. Exp. Clin. Endocrinol. Diabetes 2008, 116:481-486.
25. Koika V., et al. Association of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 with decreased basic metabolic rate in women with polycystic ovary syndrome. Eur. J. Endocrinol. 2009, 161:317-322.
26. Korhonen S., et al. Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome. Hum. Reprod. 2003, 18:540-543.
27. Legro R.S. Polycystic ovary syndrome and cardiovascular disease: a premature association?. Endocr. Rev. 2003, 24:302-312.
28. Lerchbaum E., Trummer O., Giuliani A., Gruber H.J., Pieber T.R., Obermayer-Pietsch B. Susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21, and 9q33.3 in acohort of Caucasian women. Horm. Metab. Res. 2011, 43:743-747.
29. Luan J., et al. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 2001, 50:686-689.
30. Meirhaeghe A., Cottel D., Amouyel P., Dallongeville J. Association between peroxisome proliferator activated receptor-gamma haplotypes and the metabolic syndrome in French men and women. Diabetes 2005, 54:3043-3048.
31. Narsing Rao L., Jacob J.J., Paul T.V., Rajarathinam S., Thomas N., Seshadri M.S. Effect of pioglitazone on menstrual frequency, hyperandrogenism and insulin resistance in adolescents and young adults with polycystic ovary syndrome. J. Pediatr. Adolesc. Gynecol. 2009, 22:91-95.
32. Niu W., Qi Y., Gao P., Zhu D. Angiotensin converting enzyme D allele is associated with an increased risk of type 2 diabetes: evidence from a meta-analysis. Endocr. J. 2010, 57:431-438.
33. Orio F., et al. Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2003, 88:5887-5892.
34. Orio F., et al. Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2004, 89:5110-5115.
35. San Millán J.L., Cortón M., Villuendas G., Sancho J., Peral B., Escobar-Morreale H.F. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J. Clin. Endocrinol. Metab. 2004, 89:2640-2646.
36. San-Millán J.L., Escobar-Morreale H.F. The role of genetic variation in peroxisome proliferator activated receptors in the polycystic ovary syndrome (PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence. Clin. Endocrinol. (Oxf) 2010, 72:383-392.
37. Setji T.L., Brown A.J. Polycystic ovary syndrome: diagnosis and treatment. Am. J. Med. 2006, 120:128-132.
38. Sheehan M.T. Polycystic ovarian syndrome: diagnosis and management. Clin. Med. Res. 2004, 2:13-27.
39. Stumvoll M., Häring H. The peroxisome proliferator-activated receptor-γ 2 Pro12Ala polymorphism. Diabetes 2002, 51:2341-2347.
40. Stumvoll M., Haring H. The peroxisome proliferator activated receptor 2 pro12ala polymorphism. Diabetes 2002, 51:2341-2347.
41. Tan B.K., et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008, 57:1501-1507.
42. Tellechea M.L., Aranguren F., Pérez M.S., Cerrone G.E., Frechtel G.D., Taverna M.J. Pro12Ala polymorphism of the peroxisome proliferator activated receptor-gamma gene is associated with metabolic syndrome and surrogate measures of insulin resistance in healthy men: interaction with smoking status. Circ. J. 2009, 73:2118-2124.
43. Tok E.C., Aktas A., Ertunc D., Erdal E.M., Dilek S. Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-gamma2 Pro12Ala genotype. Hum. Reprod. 2005, 20:1590-1595.
44. Unluturk U., Harmanci A., Kocaefe C., Yildiz B.O. The genetic basis of the polycystic ovary syndrome: a literature review including discussion of PPAR-gamma. PPAR. Res. 2007, 2007:1-23.
45. Vigil P., Contreras P., Alvarado J.L., Godoy A., Salgado A.M., Cortés M.E. Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome. Hum. Reprod. 2007, 22:2974-2980.
46. Wang Y., Wu X., Cao Y., Yi L., Fan H., Chen J. Polymorphisms of the peroxisome proliferator activated receptor-gamma and its coactivator-1alpha genes in Chinese women with polycystic ovary syndrome. Fertil. Steril. 2006, 85:1536-1540.
47. Wang K., Wang L., Zhao Y., Shi Y., Wang L., Chen Z.J. No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene and polycystic ovary syndrome. Hum. Reprod. 2009, 24:485-490.
48. Xita N., Lazaros L., Georgiou I., Tsatsoulis A. The Pro12Ala polymorphism of the PPAR-gamma gene is not associated with the polycystic ovary syndrome. Hormones (Athens) 2009, 8:267-272.
49. Yilmaz M., Ergün M.A., Karakoç A., Yurtçu E., Cakir N., Arslan M. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome. Gynecol. Endocrinol. 2006, 22:336-342.
50. Ziegler A., Van Steen K., Wellek S. Investigating Hardy-Weinberg equilibrium in case-control or cohort studies or meta-analysis. Breast Cancer Res. Treat. 2011, 128:197-201.